Partial splenic artery embolization in cirrhotic patients

Area of Science:

• Interventional Radiology
• Hepatology
• Hematology

Background:

• Splenomegaly is common in cirrhosis, often causing low platelets and white blood cells.
• Partial splenic artery embolization (PSE) is an established treatment for splenomegaly in cirrhosis.
• PSE is a viable option for patients unsuitable for splenectomy.

Purpose of the Study:

• To review current literature on PSE in cirrhotic patients.
• To highlight PSE techniques and summarize outcomes.
• To detail complications associated with PSE in this population.

Main Methods:

• Literature review of studies on PSE for cirrhotic splenomegaly.
• Statistical summary of hematologic improvements and complication rates.
• Analysis of techniques and patient selection criteria.

Main Results:

• PSE significantly increases platelet and leukocyte counts in cirrhotic patients.
• Hematologic indices remain improved long-term post-PSE, despite some decline.
• Common complications include post-embolization syndrome; complication rates correlate with embolized splenic volume.

Conclusions:

• PSE is an effective treatment for improving hematologic indices in cirrhotic patients with splenomegaly.
• PSE offers a valuable therapeutic option for managing complications of portal hypertension.
• Careful patient selection and procedural technique are crucial to minimize PSE complications.